EUVIMEDEUVIMED entdecken
EditorialOpen Access · CC BY-NC 4.0

New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic

Anne C Teirlinck iD, Caroline K Johannesen, Eeva K Broberg, Pasi Penttinen iD, Harry Campbell, Harish Nair, Rachel M Reeves iD, Håkon Bøås iD, Mia Brytting, Wei Cai, AnnaSara Carnahan, Jean-Sebastien Casalegno und 27 weitere

European Respiratory Journal · 2023-04 · 61 (4) · 2201569

DOI: 10.1183/13993003.01569-2022 ↗

Kurz gefasst

Editorial in der Zeitschrift European Respiratory Journal, online erschienen am 03.04.2023. Verfasst von Anne C Teirlinck und 38 weiteren Autor:innen. Beteiligte Einrichtung: National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Bilthoven, The Netherlands anne.teirlinck@ri…. Hauptthemen laut MEDLINE: COVID-19, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Respiratory Tract Infections. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, the Innovative Medicines Initiative 2 Joint Undertaking.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of SARS-CoV-2 and the resulting coronavirus disease 2019 (COVID-19) pandemic has led to the reconsideration of surveillance strategies for respiratory syncytial virus (RSV) and other respiratory viruses. The COVID-19 pandemic and the non-pharmaceutical interventions for COVID-19 had a substantial impact on RSV transmission in many countries, with close to no transmission detected during parts of the usual season of 2020–2021. Subsequent relaxation of social restrictions has resulted in unusual out-of-season resurgences of RSV in several countries, causing a higher healthcare burden and often a higher proportion of hospitalisations than usual among children older than 1 year in age [1]. In case of an emerging infectious disease with pandemic potential, preparedness to scale up surveillance for the emerging disease while continuing the maintenance of surveillance activities of pre-existing seasonal diseases is necessary. The COVID-19 pandemic demonstrated, however, a lack of surge capacity in respiratory surveillance [2]. Many of the existing respiratory surveillance systems across Europe were affected by the COVID-19 pandemic. Usual healthcare seeking routes, that are often the source of the sentinel surveillance, were altered for patients with respiratory symptoms to be diagnosed elsewhere for SARS-CoV-2 in many countries. Additionally, there were initially major reductions in testing availability, workforce numbers and access to test consumables due to repurposing of human and material resources to SARS-CoV-2 diagnostics and surveillance in the first half of 2020 [3, 4]. To help countries prioritise efforts towards construction of resilient and sustainable surveillance systems, the World Health Organization (WHO) European region and European Centre for Disease Prevention and Control (ECDC) convened Member State consultations to develop a strategic surveillance framework for a broader respiratory pathogen surveillance in the post-acute phase of the COVID-19 pandemic [5, 6]. It is important for RSV surveillance to be aligned and integrated within this broad respiratory surveillance framework for increased efficiency and sustainability of RSV surveillance. We here address the specific needs of RSV surveillance, based on the set of recommendations we proposed in 2019 [7], which we revised during a virtual workshop in October 2021, with 40 participants from 16 EU/EEA countries, representing expertise within RSV epidemiology, virology and public health. We take into consideration the need for robust surveillance of RSV to inform healthcare planning and appropriate timing of RSV prophylaxis and other preventive measures, and the lessons learned from the COVID-19 pandemic (table 1).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory Syncytial Virus, HumanRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsHumansPandemics

Autor:innen und Institutionen

  • National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, Bilthoven, The Netherlands anne.teirlinck@rivm.nl.
  • Statens Serum Institut, Copenhagen, Denmark.
  • Department of Clinical Research, Nordsjaellands Hospital, and University of Copenhagen, Department of Public Health, Copenhagen, Denmark.
  • European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Independent researcher, Edinburgh, UK.

ORCID-Profile: Anne C Teirlinck, Pasi Penttinen, Rachel M Reeves, Håkon Bøås, Kostas Danis, Jesus Angel Oliva, Richard Osei-Yeboah, Karol Szymanski, Sylvie van der Werf, Adam Meijer

Förderung

  • World Health Organization
  • the Innovative Medicines Initiative 2 Joint Undertaking

Zitieren

APA

Teirlinck, A. C., Johannesen, C. K., Broberg, E. K., Penttinen, P., Campbell, H., Nair, H., Reeves, R. M., Bøås, H., Brytting, M., Cai, W., Carnahan, A., Casalegno, J. S., Danis, K., De Gascun, C., Ellis, J., Emborg, H. D., Gijon, M., Guiomar, R., Hirve, S. S., …, & Fischer, T. K. (2023). New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic. European Respiratory Journal, 61(4), 2201569. https://doi.org/10.1183/13993003.01569-2022

Vancouver

Teirlinck AC, Johannesen CK, Broberg EK, Penttinen P, Campbell H, Nair H, et al. New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic. European Respiratory Journal. 2023;61(4):2201569. doi:10.1183/13993003.01569-2022

BibTeX
@article{Teirlinck2023,
  author = {Teirlinck, Anne C and Johannesen, Caroline K and Broberg, Eeva K and Penttinen, Pasi and Campbell, Harry and Nair, Harish and Reeves, Rachel M and Bøås, Håkon and Brytting, Mia and Cai, Wei and Carnahan, AnnaSara and Casalegno, Jean-Sebastien and Danis, Kostas and De Gascun, Cillian and Ellis, Joanna and Emborg, Hanne-Dorthe and Gijon, Manuel and Guiomar, Raquel and Hirve, Siddhivinayak S and Jiřincová, Helena and Nohynek, Hanna and Oliva, Jesus Angel and Osei-Yeboah, Richard and Paget, John and Pakarna, Gatis and Pebody, Richard and Presser, Lance and Rapp, Marie and Reiche, Janine and Rodrigues, Ana Paula and Seppälä, Elina and Socan, Maja and Szymanski, Karol and Trebbien, Ramona and Večeřová, Jaromíra and van der Werf, Sylvie and Zambon, Maria and Meijer, Adam and Fischer, Thea K},
  title = {New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic},
  journal = {European Respiratory Journal},
  year = {2023},
  volume = {61},
  number = {4},
  pages = {2201569},
  doi = {10.1183/13993003.01569-2022}
}
Kostenlos starten →